A Review on Analytical Methods for Ivabradine determination in Pharmaceutical Dosage Forms
Ivabradine is a specific heart rate lowering agent, acting by reducing the rate of pacemaker activity in the sinoatrial node. Ivabradine is a novel heart rate lowering medicine for the symptomatic management of stable angina pectoralis and symptomatic chronic heart failure. In multicenter clinical trials, it has been proved that Ivabradine is superior to beta-blocking agents during complex therapy of chronic heart failure accompanied with its beneficial effects related to cardiac remodeling, improvement of the currency of heart failure and diminution of patients rehospitalisation. It is suggested that Ivabradine as a newer agent is a valuable perspective drug for the treatment of congestive heart failure. This review is useful for the future study for researcher involved in formulation development and quality control of Ivabradine.
This review article represents the various analytical methods which have been reported for estimation of Ivabradine in pharmaceutical dosage form. The spectrophotometric techniques and Q-absorbance ratio method were reported by the various authors. Many researchers also worked in chromatographic areas like Thin layer chromatography, High performance liquid chromatography, and High performance thin layer chromatography. Ivabradine is also studied by various hyphenated techniques .We reviewed and reported almost all analytical methods with more emphasis on chromatographic mrthodsfor Ivabradine.
CAO Lu-ye, JI Xiu-mei, BAO Yuan-wu (2014); Determination of Ivabradine hydrochloride in the human plasma and the bioequivalence study by LC-MS/MS JIA; West China Journal of Pharmaceutical Sciences; [en.cnki.com.cn/Article_en/CJFDTOTAL-HXYO201402026.htm]
Corlanor® is a first-in-class, HCN channel blocker that lowers heart rate: https://www.corlanorhcp.com/mechanism-of-action/
Damle MC, Bagwe RA. (2015); Development and Validation of Stability-Indicating HPTLC Method for Ivabradine HCl; An International Journal of Pharmaceutical Science, 6(1); 141- 152
Difrancesco D, Camm JA (2004); Heart rate lowering by specific and selective I(f) current inhibition with ivabradine Drugs; 64(16); 1757-1765.
http://www.chemspider.com/Chemical-Structure.117373.html (accesed 7 July 2018)
https://en.wikipedia.org/wiki/Ivabradine (accesed 7 July 2018)
Maheshwaria S., Khandharb A., Jaina A (2010); Quantitative Determination and Validation of Ivabradine HCL by Stability Indicating RP-HPLC Method and Spectrophotometric Method in Solid Dosage Form”; Eurasian Journal of Analytical Chemistry; 5(1); 53-62.
MaryseFrançois-Bouchard, GillesSimonin, Marie-JeanneBossant, ClaireBoursier-Neyret (2000); Simultaneous determination of ivabradine and its metabolites in human plasma by liquid chromatography--tandem mass spectrometry; Journal of Chromatography B: Biomedical Sciences and Applications; 745(2); 261-9
Motisariya M.H., GovindbhaiPatel K.,ShahP.A. (2013); Validated stability-indicating high performance thin layer chromatographic method for determination of Ivabradine hydrochloride in bulk and marketed formulation”; An application to kinetic study .Bulletin of Faculty of Pharmacy, Cairo university; 51(2); 233-241.
Nadia M. M, Fayez Y. M., Farid J., Abd El-Aziz B. Abd El-Alim (2016); Validated Stability Indicating Chromatographic Methods for Determination of Ivabradine Hydrochloride in the Presence of Its Acidic Degradation Product; International Journal of Research and Reviews in Pharmacy and Applied sciences ; (1) ; 1370-1380.
O’Neil MJ. (2006); The Merck Index, an Encyclopedia of Chemicals, Drugs and Biologicals. 4th Ed. Whitehouse Station: Merck Research Laboratories, Division of Merck and Co., Inc.; 907.
Panda S., Patra S. (2014); Rapid and Selective UV Spectrophotometric and RP-HPLC Methods for Dissolution Studies of Ivabradine Controlled release formulations; PharmaTutor; 2(8); 201-213.
Patel H., Jivani N. (2015); Development Of Validated Rp-Hplc Method For Simultaneous Estimation Of Carvedilol And Ivabradine; World Journal of Pharmacy and Pharmaceutical Sciences; 4(5); 630-639.
Patel P.N., Borkar R.M., Kalariya P.D., Gangwal R.P., Sangamwar A.T., Samanthula G, Ragampeta S (2015); Characterization of degradation products of Ivabradine by LC-HR-MS/MS: a typical case of exhibition of different degradation behavior in HCl and H2SO4 acid hydrolysis; Journal of Mass Spectrometry; 50(2); 344-353.
Patil P, Hasumati A. Raj,Sonora G. (2016); Q-absorbance ratio spectrophotometric method for simultaneous determination of atenolol and ivabradine hydrochloride in synthetic mixture; Pharmaceutical and Biological Evaluations; 3(2) ; 224-230.
Piotr P., Nowakowska J., Krzesimir Ciura (2013); Chromatographic analysis of ivabradine on polar, nonpolar and chemically modified adsorbents by HPTLC; Journal of Food and drug analysis; 21(2); 165-168
Rahman Md. Rezowanur, Asaduzzaman Md. , Ashraful Islam S. M.(2012); Development and validation of RP-HPLC method for analysis of Ivabradine Hydrochloride in tablet dosage forms; Research Journal of Pharmaceutical, Biological and Chemical Sciences; 3(3); 1032-1043.
Seerapu S, Srinivasan B. P. (2010); Development and Validation of RP-HPLC Method for the Estimation of Ivabradine Hydrochloride in Tablets; International journal of Pharmaceutical Sciences; 72(5); 667–671.
Sulfi S, Timmis A.D. (2006); Ivabradine – the first selective sinus node If channel inhibitor in the treatment of stable angina; International Journal of Clinical Practice; 60(2); 222-228.
Xiaoli Y., Hui L.,Cui L.(2011); Determination of the Related Substances in Ivabradine Hydrochloride and Its Tablets by HPLC; Chinese Pharmaceutical Affairs. [en.cnki.com.cn/Article_en/CJFDTOTAL-ZGYS201105022.htm]